Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that increases through reinvestment and annual raises [1] Group 2 - The article expresses personal opinions and is not intended as investment advice [2] - It emphasizes the importance of conducting individual research before making investment decisions [2]

Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: Conagra Brands Inc (CAG) - Conagra Brands has a dividend yield of 8.20% [6] - Deutsche Bank analyst Steve Powers maintained a Hold rating and reduced the price target from $19 to $18, with an accuracy rate of 66% [6] - Morgan Stanley analyst Megan Alexander maintained an Equal-Weight rating and lowered the price target from $21 to $19, with an accuracy rate of 67% [6] - Recent news indicates that Conagra Brands posted mixed quarterly results on December 19 [6] Group 2: Altria Group Inc (MO) - Altria Group has a dividend yield of 7.19% [6] - B of A Securities analyst Lisa Lewandowski maintained a Buy rating and raised the price target from $64 to $72, with an accuracy rate of 58% [6] - Barclays analyst Gaurav Jain maintained an Underweight rating and increased the price target from $49 to $57, with an accuracy rate of 57% [6] - Recent news includes the retirement of CEO Billy Gifford and the appointment of Sal Mancuso as his successor on December 11 [6] Group 3: Flowers Foods Inc (FLO) - Flowers Foods has a dividend yield of 9.11% [6] - DA Davidson analyst Brian Holland maintained a Neutral rating with a price target of $15, with an accuracy rate of 53% [6] - Jefferies analyst Rob Dickerson maintained a Hold rating and reduced the price target from $23 to $20, with an accuracy rate of 64% [6] - Recent news shows that Flowers Foods posted in-line quarterly earnings on November 6 [6]

Core Insights - During market turbulence, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividends [1] Group 1: Conagra Brands Inc (NYSE:CAG) - Conagra Brands has a dividend yield of 8.20% [6] - Deutsche Bank analyst Steve Powers maintained a Hold rating and reduced the price target from $19 to $18, with an accuracy rate of 66% [6] - Morgan Stanley analyst Megan Alexander maintained an Equal-Weight rating and lowered the price target from $21 to $19, with an accuracy rate of 67% [6] - Recent news indicates that Conagra Brands posted mixed quarterly results on December 19 [6] Group 2: Altria Group Inc (NYSE:MO) - Altria Group has a dividend yield of 7.19% [6] - B of A Securities analyst Lisa Lewandowski maintained a Buy rating and raised the price target from $64 to $72, with an accuracy rate of 58% [6] - Barclays analyst Gaurav Jain maintained an Underweight rating and increased the price target from $49 to $57, with an accuracy rate of 57% [6] - Recent news includes the retirement of CEO Billy Gifford and the appointment of Sal Mancuso as his successor on December 11 [6] Group 3: Flowers Foods Inc (NYSE:FLO) - Flowers Foods has a dividend yield of 9.11% [6] - DA Davidson analyst Brian Holland maintained a Neutral rating with a price target of $15, with an accuracy rate of 53% [6] - Jefferies analyst Rob Dickerson maintained a Hold rating and reduced the price target from $23 to $20, with an accuracy rate of 64% [6] - Recent news shows that Flowers Foods posted in-line quarterly earnings on November 6 [6]

Group 1 - Altria Group, Inc. is recognized as one of the Best Stocks for a Dividend Achievers List, highlighting its strong dividend performance [1] - Bank of America analyst Lisa Lewandowski has reduced the price target for Altria from $66 to $64 while maintaining a Buy rating, indicating a cautious outlook on consumption growth in the consumer staples sector [2] - Despite declining cigarette shipments, Altria has managed to stabilize revenue and earnings through price increases, as tobacco users tend to remain loyal to their preferred brands [2] Group 2 - The dividend is a central aspect of Altria's investment case, with a target payout ratio of about 80% of adjusted earnings per share, which provides flexibility in a slow-growth environment [3] - Altria's portfolio includes well-known tobacco brands such as Marlboro, Black & Mild, Copenhagen, Skoal, and Virginia Slims, reinforcing its market presence [4]

Core Insights - Altria Group, Inc. and Philip Morris International Inc. are major players in the global tobacco industry, each with unique geographic exposure and strategic focuses [1][2] - Altria has a market capitalization of approximately $98.5 billion, primarily focused on the U.S. market, while Philip Morris has a larger market cap of about $248.6 billion, reflecting its international presence and innovation in reduced-risk products [1][2] Altria's Position - Altria maintains a strong position in the U.S. tobacco market, with a 64.4% adjusted operating companies income margin in Q3 2025, indicating strong pricing power despite declining cigarette volumes [3][6] - The company is investing in smoke-free products, with on! nicotine pouch shipments reaching 133.6 million cans year-to-date, and continues to innovate with products like on! PLUS and Horizon's Ploom [4][8] - Altria increased its quarterly dividend by 3.9% to $1.06 per share in August 2025, marking its 60th dividend increase in 56 years, and expanded its share-repurchase authorization to $2 billion through 2026 [5] - Domestic cigarette shipment volumes declined by 8.2% in Q3, and Marlboro's market share decreased by 1.2 percentage points to 40.4%, highlighting ongoing challenges [6] Philip Morris' Growth - Philip Morris is increasingly focused on smoke-free products, which accounted for 41% of total net revenues and 42% of gross profit in Q3 2025, with shipments growing by 16.6% year-over-year [7][9] - Key smoke-free brands like IQOS, ZYN, and VEEV are driving revenue growth, with IQOS leading in heated tobacco globally [9] - Operational discipline and cost controls have supported margin expansion and earnings growth, while the combustible segment remains under pressure with a 3.2% decline in cigarette shipment volumes [10][11] Earnings Estimates - The Zacks Consensus Estimate for Altria's EPS indicates a year-over-year increase of approximately 6.3% for 2025 and 2.3% for 2026, remaining unchanged at $5.44 and $5.56 respectively [12] - For Philip Morris, the consensus estimate implies year-over-year growth of 14.2% for 2025 and 11.3% for 2026, with estimates slightly down to $7.50 and $8.35 [14] Stock Performance and Valuation - Over the past year, Altria's shares have increased by 17.4%, while Philip Morris has seen a stronger gain of 33.9% [15] - Altria's forward P/E ratio is 10.54, below its one-year median of 10.80, while Philip Morris' forward P/E ratio stands at 19.17, also below its median of 20.59 [16] Investment Appeal - Philip Morris offers stronger global growth and leadership in reduced-risk products, while Altria provides a compelling value proposition with higher income visibility and resilient margins [17] - Altria is viewed as a better option for income-focused investors seeking stability and consistent returns amid the industry's transition to smoke-free products [17]

Core Insights - Companies with a long history of dividend increases are likely candidates for future dividend raises, indicating stability and reliability in their financial performance [1]. Company Summaries - **Procter & Gamble**: The company has raised its dividend for 69 years, with a recent revenue increase of 2% to $84.3 billion and operating cash flow of $17.8 billion. Its forward yield is approximately 3% [2]. - **Johnson & Johnson**: This company has increased its dividend for 63 consecutive years, recently raising it by 4.8%. In the last quarter, revenue rose 7% to $24 billion, and per-share earnings surged 91% to $2.12. The company also raised its 2025 sales outlook [3]. - **Altria**: Altria has increased its dividend to $1.06 from $1.02, marking the 60th increase in 56 years. From 2020 to 2024, it has paid out $32 billion in dividends and conducted $7.8 billion in stock buybacks. Altria is known for its Marlboro brand [4]. - **Coca-Cola**: The company announced its 63rd consecutive annual dividend increase, raising the quarterly dividend by approximately 5.2% from 48.5 cents to 51 cents per share. Coca-Cola reported revenue of $12.5 billion, up 5%, with earnings rising 30% to $0.86 per share [5].

Core Insights - Altria Group, Inc. has authorized an expansion of its share repurchase program from $1 billion to $2 billion, extending the program's expiration to December 31, 2026, indicating a strong commitment to returning value to shareholders [2][9] Capital Allocation Strategy - The decision to increase the buyback program follows a period of active repurchases in 2025, where Altria repurchased 1.9 million shares at an average price of $60.13, spending $112 million in Q3 2025, and a total of 12.3 million shares for $712 million in the first nine months of 2025 [3][9] - The structure of the expanded buyback program suggests a steady approach, allowing Altria to maintain discretion over timing while reinforcing buybacks as a key component of its capital return strategy [4] Earnings and Valuation - The expanded buyback may help mitigate modest earnings per share pressure due to declining cigarette volumes, reflecting confidence in Altria's cash generation and disciplined capital allocation [5] - Altria's shares have gained 1.3% in the past month, compared to the industry's growth of 3.1%, and the company trades at a forward price-to-earnings ratio of 10.45X, lower than the industry average of 14.26X [8][11] Earnings Estimates - The Zacks Consensus Estimate for Altria's earnings implies year-over-year growth of 6.3% for 2025 and 2.3% for 2026, with current estimates for the current year at $5.44 and next year at $5.56 [12][13]

Core Viewpoint - Altria Group Inc. continues to thrive in a challenging economic environment, supported by a strong dividend history and significant cash flow, making it an attractive investment option despite the declining cigarette usage trend in the U.S. [1][2][6] Financial Performance - Altria's revenue for the most recent quarter was $5.3 billion, reflecting a 6% year-over-year decline, while adjusted diluted earnings per share (EPS) increased by 6% to $1.23 [7] - The company maintains a guidance of a 2% to 5% increase in EPS for the full year, indicating confidence in its financial outlook [7] Dividend Policy - Altria has raised its dividend for 56 consecutive years, with a current dividend of $4.24, resulting in a forward yield of 7.3%, enhancing its appeal during stock market downturns [2][4] - The company plans to continue increasing its dividend through 2028, supported by strong cash flow and a robust balance sheet [2] Market Context - Approximately 29 million Americans smoke cigarettes, contributing to Altria's sustained revenue despite a modest decline in overall cigarette use over the past decade [4][6] - The ongoing affordability crisis, characterized by rising prices for essential goods, positions Altria's products as inflation-proof, potentially making it a favorable investment choice [5][8]

For some Americans, cigarettes are an essential product, despite the cost of smoking averaging $3,000 per smoker per year. ...

Core Points - The U.S. Food and Drug Administration (FDA) has authorized the marketing of six nicotine pouch products owned by Altria [1] - This authorization is part of a pilot program designed to expedite the review process for such products [1] Company Summary - Altria has received FDA approval for six of its nicotine pouch products, indicating a significant step in the company's product portfolio expansion [1] - The pilot program aims to streamline the regulatory process for nicotine products, potentially benefiting Altria and similar companies in the industry [1] Industry Summary - The FDA's initiative reflects a broader trend towards the regulation and acceptance of alternative nicotine delivery systems [1] - The approval of these products may influence market dynamics and competition within the nicotine pouch segment [1]